Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats

Pharmacology, Toxicology and Pharmaceutical Science

• Levodopa 70%
• Dyskinesia 50%
• Rat 40%
• Peroxisome Proliferator Activated Receptor 30%
• Levodopa-Induced Dyskinesia 30%
• Anandamide 20%
• Cannabinoid 1 Receptor 20%
• Rosiglitazone 20%
• Capsazepine 20%
• URB597 20%
• Dopamine 10%
• Receptor 10%
• Bioavailability 10%
• Complication 10%
• Receptor Subtype 10%
• Transcription Factor 10%
• Dynorphin 10%
• Parkinson Disease 10%
• Vanilloid Receptor 1 10%
• Peroxisome Proliferator Activated Receptor Gamma 10%
• Antiparkinson Agent 10%

Neuroscience

• L-DOPA 100%
• Dyskinesia 40%
• Peroxisome Proliferator-Activated Receptor 30%
• Capsazepine 20%
• Anandamide 20%
• Cannabinoid 1 Receptor 20%
• Rosiglitazone 20%
• URB597 20%
• Eicosanoid Receptor 10%
• Phosphorylation 10%
• Transcription Factors 10%
• Dopamine 10%
• Catabolism 10%
• Vanilloid Receptor 1 10%
• Parkinson's Disease 10%
• Receptor Subtype 10%
• Dynorphin 10%
• Striatum 10%
• Peroxisome Proliferator-Activated Receptor Gamma 10%